L. Leal

Reproducibility of a 12-gene set for predicting outcome and benefit from ACT in early-stage NSCLC patients

A. Fabro, C. Souto-Moura, S. Batah, 2023, Lung cancer.

Validation of a 5-gene signature for predicting outcomes in early-stage NSCLC patients

A. Fabro, C. Souto-Moura, S. Batah, 2023, Lung cancer.

Fluid-specific miRNA-based signatures for lung cancer screening

A. C. Laus, Luciane Sussuchi da Silva, R. Chiarantano, 2023, Lung cancer.

Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC

P. de Marchi, R. Cavagna, L. D. da Silva, 2023, Translational oncology.

Molecular profile of driver genes in lung adenocarcinomas of Brazilian patients who have never smoked: implications for targeted therapies.

G. Berardinelli, M. Molina-Vila, F. Escremim de Paula, 2024, The oncologist.

HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer

Xueting Cai, M. Molina-Vila, J. Codony-Servat, 2024, Lung Cancer.

Biological and therapeutic implications of RKIP in Gastrointestinal Stromal Tumor (GIST): an integrated transcriptomic and proteomic analysis

M. Melendez, A. Evangelista, N. Campanella, 2023, Cancer Cell International.